15 August 2018
Visiongain’s new report Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Forecast 2017-2027 North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing report indicates that the Global Pharma CMOs Market will see $105.3bn in spending in 2021.
The global pharmaceutical contract manufacturing
market was valued at $76.6bn in 2016 and is expected to grow at a CAGR of 6.6% in the first half of the forecast period. Between 2011 and 2016, the top 5 emerging market CMOs grew at a CAGR of 13.6%, whereas the leading developed market CMOs grew at a CAGR of 1.7% over the same period.
The lead analyst of the report said: “Market drivers will stem from the increased demand for outsourcing in developed markets, particularly from big pharma companies. These companies will increasingly look to form long-term strategic partnerships with global CMOs, demanding services from pre-clinical formulation development through to commercial supply. Big pharma companies are looking to reduce fixed cost and simplify their outsourced service supplier networks, forming strategic partnerships with just a few service providers. However, demand for specialist services, as well as the need for local, small-scale manufacturing from pharmaceutical start-ups, will drive growth for smaller, specialist CMOs.
While growth is forecast for this market throughout the period 2017-2027, restraining factors exist. The highly-fragmented nature of the market means that it is very competitive and not all companies are likely to prosper or survive. Those that have expanded too quickly, investing in increased capacity, may not be able to find the demand to cover investments. Factors impacting overcapacity will include the development of targeted therapies and orphan drugs, which have smaller target patient populations and hence require smaller quantities of drug to be manufactured.”
The 311-page report contains 184 tables and 111 figures that add visual analysis in order to explain the developing trends within the Global Pharma CMOs market.
Visiongain provides revenue forecasts for the period 2017-2027 for the global CMOs market as well as the leading segments of that market: API, FDF and Other Services
Furthermore, this report profiles 30 leading CMOs in North America, Europe, Japan, China and India.
The content of each profile differs, depending on the organisation. In general, a profile gives the following information: Overview of the company’s contract manufacturing services and operations, analysis of recent financial performance, activities, acquisitions, production capacity, deals, new service offerings and collaborations, SWOT analysis, forecasting of pharmaceutical manufacturing revenue to 2027, as well as projected operating profit and margin for some companies.
The Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Forecast 2017-2027 North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing report will be of value to anyone who wants to better understand the Pharma CMOs market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the Pharma CMOs industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.
11 October 2021
High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.
07 October 2021
Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.
06 October 2021
Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market